Cargando…

Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure

Sacubitril/valsartan (S/V) is a pharmaceutical strategy that increases natriuretic peptide levels by inhibiting neprilysin and regulating the renin-angiotensin-aldosterone pathway, blocking AT1 receptors. The data for this innovative medication are mainly based on the PARADIGM-HF study, which includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iovanovici, Diana-Carina, Bungau, Simona Gabriela, Vesa, Cosmin Mihai, Moisi, Madalina, Babes, Elena Emilia, Tit, Delia Mirela, Horvath, Tunde, Behl, Tapan, Rus, Marius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570001/ https://www.ncbi.nlm.nih.gov/pubmed/36232632 http://dx.doi.org/10.3390/ijms231911336

Ejemplares similares

The Rare Condition of Left Ventricular Non-Compaction and Reverse Remodeling
por: Bustea, Cristiana, et al.
Publicado: (2023)

A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon
por: Pantea-Roșan, Larisa Renata, et al.
Publicado: (2022)

Myocardial Viability Testing in the Management of Ischemic Heart Failure
por: Babes, Elena Emilia, et al.
Publicado: (2022)

Risk Factors Associated with Recurrent Clostridioides difficile Infection
por: Negrut, Nicoleta, et al.
Publicado: (2020)

Value of Hematological and Coagulation Parameters as Prognostic Factors in Acute Coronary Syndromes
por: Babes, Elena Emilia, et al.
Publicado: (2021)

Withaferin A—A Promising Phytochemical Compound with Multiple Results in Dermatological Diseases
por: Bungau, Simona, et al.
Publicado: (2021)

Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease
por: Pavel, Flavia Maria, et al.
Publicado: (2021)

No-Reflow after PPCI—A Predictor of Short-Term Outcomes in STEMI Patients
por: Pantea-Roșan, Larisa Renata, et al.
Publicado: (2020)

Framing Cause-Effect Relationship of Acute Coronary Syndrome in Patients with Chronic Kidney Disease
por: Moisi, Mădălina Ioana, et al.
Publicado: (2021)

Clinical, Pathological and Microbiological Evaluation of Diabetic Foot Syndrome
por: Uivaraseanu, Bogdan, et al.
Publicado: (2020)

Antibiotic Consumption and Microbiological Epidemiology in Surgery Departments: Results from a Single Study Center
por: Zaha, Dana Carmen, et al.
Publicado: (2020)

Highlighting the Benefits of Rehabilitation Treatments in Hip Osteoarthritis
por: Radu, Andrei-Flavius, et al.
Publicado: (2022)

Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021)

Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors
por: Vesa, Cosmin Mihai, et al.
Publicado: (2020)

Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics
por: Moisi, Mădălina Ioana, et al.
Publicado: (2020)

Left Ventricle Outflow Tract Velocity-Time Index and Right Ventricle to Left Ventricle Ratio as Predictors for in Hospital Outcome in Intermediate-Risk Pulmonary Embolism
por: Babes, Elena Emilia, et al.
Publicado: (2022)

Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir
por: Negru, Paul Andrei, et al.
Publicado: (2022)

Emerging Insights into the Applicability of Essential Oils in the Management of Acne Vulgaris
por: Bungau, Alexa Florina, et al.
Publicado: (2023)

Predictors of Readmission after the First Acute Coronary Syndrome and the Risk of Recurrent Cardiovascular Events—Seven Years of Patient Follow-Up
por: Bustea, Cristiana, et al.
Publicado: (2023)

Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021)

Eligibility and Usage of Sacubitril/Valsartan in Korea
por: Kim, Jin-Jin, et al.
Publicado: (2019)

Antioxidant and Hypoglycemic Potential of Essential Oils in Diabetes Mellitus and Its Complications
por: Bungau, Simona Gabriela, et al.
Publicado: (2023)

Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
por: Gori, Mauro, et al.
Publicado: (2021)

Pharmacotherapy Evolution in Alzheimer’s Disease: Current Framework and Relevant Directions
por: Miculas, Denisa Claudia, et al.
Publicado: (2022)

Insights into implementation of sacubitril/valsartan into clinical practice
por: Martens, Pieter, et al.
Publicado: (2018)

Sacubitril–valsartan in heart failure and multimorbidity patients
por: Rodil Fraile, Raquel, et al.
Publicado: (2018)

Re: Implication of low‐dose sacubitril/valsartan
por: Pandey, Amitabh C., et al.
Publicado: (2021)

Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
por: Mustafa, Nor Hidayah, et al.
Publicado: (2022)

Effects of Sacubitril/Valsartan on the Renal Resistance Index
por: Gioia, Margherita Ilaria, et al.
Publicado: (2022)

Cardiometabolic Risk: Characteristics of the Intestinal Microbiome and the Role of Polyphenols
por: Haș, Ioana Mariana, et al.
Publicado: (2023)

The Effects of the ‘Catabolic Crisis’ on Patients’ Prolonged Immobility after COVID-19 Infection
por: Moga, Titus David, et al.
Publicado: (2022)

Morbidity and Mortality in Patients with Acute Coronary Syndrome with and without Chronic Kidney Disease and Physicans Atitude Regarding Theraphy in the Two Groups
por: Moisi, Mădălina Ioana, et al.
Publicado: (2021)

Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023)

Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
por: Anderson, Sarah L, et al.
Publicado: (2018)

The Diuretic Effect of Sacubitril/Valsartan Might Be Clinically Relevant
por: Beck-da-Silva, Luís, et al.
Publicado: (2019)

Practical guidance on the use of sacubitril/valsartan for heart failure
por: Sauer, Andrew J., et al.
Publicado: (2018)

Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma
por: Andersen, Ulrik Ø, et al.
Publicado: (2020)

Effectiveness of sacubitril–valsartan in cancer patients with heart failure
por: Martín‐Garcia, Ana, et al.
Publicado: (2020)

Renin profiling predicts neurohormonal response to sacubitril/valsartan
por: Vergaro, Giuseppe, et al.
Publicado: (2020)

Sacubitril/valsartan in the treatment of systemic right ventricular failure
por: Zandstra, Tjitske E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_63vtstllboevgbljbt3qgdl0en